Specifically, both PEMFs and BMP2 alone enhanced ALK2 expression (PEMFs: 2.8-fold at 14 days; 2.1-fold at 28 days; BMP2: 2.05-fold at 28 days) compared to OM. Here, ACVR1 is linked to ocular melanoma.